My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 179

    1.

    Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels?

    Mulrow CD, Townsend RR.

    Ann Intern Med. 2003 Aug 19;139(4):296-8. No abstract available. PMID: 12965986 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

    Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

    Ann Intern Med. 2003 Aug 19;139(4):244-52.PMID: 12965979 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Blood pressure and urine protein levels with the least risk for worsening kidney disease.

    [No authors listed]

    Ann Intern Med. 2003 Aug 19;139(4):I36. No abstract available. PMID: 12965997 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antihypertensive therapy and progression of chronic renal disease.

    Dworkin LD, Shemin DG.

    Curr Hypertens Rep. 1999 Oct;1(5):417-22.PMID: 10981100 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?

    Weir MR.

    Curr Hypertens Rep. 2000 Dec;2(6):497-9. Review. No abstract available. PMID: 11062593 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evolution of drugs that preserve renal function.

    Basta E, Bakris GL.

    J Clin Pharmacol. 2000 Sep;40(9):978-89. Review.PMID: 10975069 [PubMed - indexed for MEDLINE]Related articles

    7.

    Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.

    Am J Kidney Dis. 2007 Dec;50(6):908-17.PMID: 18037091 [PubMed - indexed for MEDLINE]Related articles

    8.

    Summaries for patients. Using a type of blood pressure medicine, angiotensin-converting enzyme inhibitors, to prevent worsening of kidney disease unrelated to diabetes.

    ACE Inhibition in Progressive Renal Disease Study Group.

    Ann Intern Med. 2001 Jul 17;135(2):S-21. No abstract available. PMID: 11463005 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.

    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.

    Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.PMID: 15835375 [PubMed - indexed for MEDLINE]Related articles

    10.

    ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?

    Bakris GL.

    J Clin Hypertens (Greenwich). 2007 Jun;9(6):413-5. No abstract available. PMID: 17541325 [PubMed - indexed for MEDLINE]Related articles

    11.

    The role of systemic hypertension in the progression of nondiabetic renal disease.

    Marcantoni C, Jafar TH, Oldrizzi L, Levey AS, Maschio G.

    Kidney Int Suppl. 2000 Apr;75:S44-8. Review.PMID: 10828761 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

    Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS.

    Ann Intern Med. 2005 Mar 1;142(5):342-51.PMID: 15738453 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Renal protection in hypertensive patients: selection of antihypertensive therapy.

    Wenzel RR.

    Drugs. 2005;65 Suppl 2:29-39. Review.PMID: 16398060 [PubMed - indexed for MEDLINE]Related articles

    14.

    Antihypertensive therapy in the presence of proteinuria.

    Sarafidis PA, Khosla N, Bakris GL.

    Am J Kidney Dis. 2007 Jan;49(1):12-26. Review.PMID: 17185142 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hypertension and progression of renal disease.

    Maschio G, Oldrizzi L, Marcantoni C, Rugiu C.

    J Nephrol. 2000 May-Jun;13(3):225-7. Review.PMID: 10928300 [PubMed - indexed for MEDLINE]Related articles

    16.

    Summaries for patients. A low blood pressure target prevented kidney failure in patients with chronic kidney disease.

    [No authors listed]

    Ann Intern Med. 2005 Mar 1;142(5):I42. No abstract available. PMID: 15738448 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Role of hypertension in the progression of chronic renal disease.

    Martínez-Maldonado M.

    Nephrol Dial Transplant. 2001;16 Suppl 1:63-6. Review.PMID: 11369824 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Angiotensin converting enzyme inhibitors in nondiabetic renal disease.

    Maschio G, Marcantoni C.

    Curr Opin Nephrol Hypertens. 1998 May;7(3):253-7. Review.PMID: 9617554 [PubMed - indexed for MEDLINE]Related articles

    19.

    Introduction: nature of microalbuminuria, proteinuria, and progressive renal disease.

    Mogensen CE.

    J Diabetes Complications. 1995 Jan-Mar;9(1):2-6. Review. No abstract available. PMID: 7734738 [PubMed - indexed for MEDLINE]Related articles

    20.

    Compelling drug indications in diabetic and nondiabetic nephropathy.

    Ritz E, Dikow R, Zeier M.

    Curr Hypertens Rep. 2004 Aug;6(4):293-9. Review.PMID: 15257864 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity